Апалутамид снизил риск метастазов или смерти на 51% — News-Medical
Апалутамид снизил риск метастазов или смерти на 51% — News-Medical UA.NEWS
Апалутамид снизил риск метастазов или смерти на 51% — News-Medical UA.NEWS
EORTC – 7th Quality of Life in Cancer Clinical Trials Conference 2027 Oncodaily
Study establishes new perioperative standard in prostate cancer News-Medical
Рак можно принять за геморрой: онколог назвала симптомы, которые нельзя игнорировать 24.kz
Рак можно принять за геморрой: онколог назвала симптомы, которые нельзя игнорировать 24.kz
Японию хотят привлечь к диагностике рака в Кыргызстане 24.KG
Triple-negative breast cancers, which are more frequently diagnosed in younger women, are a subtype of breast tumor characterized by the absence of hormone receptors and HER2 overexpression. As a result, they do not respond to hormone therapy or HER2-targeted treatments. Their prognosis is generally less favorable…
OHSU Knight Cancer Community Symposium 2027 Oncodaily
Late-breaking: Novel alpha radiopharmaceutical therapy shows promising activity in phase 1 prostate cancer trial EurekAlert!
New alpha-emitting radiopharmaceutical therapy achieves strong responses in advanced prostate cancer News-Medical
Emad Shash: Why AI in Cancer Care Needs Both Vision and Clinical Judgment? Oncodaily
Утверждается, что вакцина против рака снижает риск развития рака кожи у чернокожих на 42 процента. gov-pmr.org
With around 75,000 new cases per year, breast cancer is by far the most common cancer among women in Germany. Using digital breast tomosynthesis in the breast cancer screening program could prevent around a quarter of invasive interval cancers that occur within two years after a digital mammogram.
Less Can Be More in Breast Cancer Treatment, Precision Oncology Editors Argue Bioengineer.org
Roche gets a lung cancer win with its KRAS drug divarasib STAT